Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Jason Westin is the Director of the Lymphoma Clinical Research Program and the Section Chief for Aggressive Lymphoma at the University of Texas MD Anderson Cancer Center in the Department of Lymphoma and Myeloma. His research interests include designing and conducting innovative clinical trials, the development of new drugs and new methods to improve outcomes for patients with lymphoma, including the study of scale-free networks and complex systems. Dr. Westin believes that clinical research is our best weapon in the fight against cancer, and has designed and conducted numerous clinical trials to find new cures for cancer.
Dr. Westin has presented his research at national and international conferences, including the American Society of Hematology, the American Society of Clinical Oncology, the American College of Clinical Pharmacology, and the Lymphoma Research Foundation.